Immatics Uses Genedata Biologics for Novel T Cell Receptor-Based Immunotherapy R&D

Rather than embarking on a complex and time-consuming software customization effort, Immatics leverages Genedata Biologics’ out-of-the-box functionality to streamline CGT workflows and increase R&D efficiency.

In this case study, learn how close collaboration with Genedata enabled rapid configuration of CGT-specific workflows and laboratory instrument integration, supporting a fast, straightforward platform rollout for T cell receptor-based immunotherapy research.